Bristol-Myers Squibb Company is a global biopharmaceutical firm founded in 1887 that discovers, develops, licenses, manufactures, markets, distributes, and sells innovative medicines worldwide. Its po... Bristol-Myers Squibb Company is a global biopharmaceutical firm founded in 1887 that discovers, develops, licenses, manufactures, markets, distributes, and sells innovative medicines worldwide. Its portfolio addresses critical therapeutic areas including oncology, hematology, immunology, cardiovascular disease, neuroscience, and other medical needs. Key products include Eliquis, which reduces the risk of stroke and systemic embolism in non-valvular atrial fibrillation and treats deep vein thrombosis and pulmonary embolism; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for rheumatoid arthritis and psoriatic arthritis; and Sprycel for Philadelphia chromosome-positive chronic myeloid leukemia. With approximately 34,100 employees and headquarters in New York, the company generates substantial revenue, reporting trailing twelve-month figures of US$48.03 billion alongside earnings of US$6.04 billion. Bristol-Myers Squibb Company plays a pivotal role in advancing healthcare through its focus on high-unmet-need diseases, contributing to the pharmaceutical industry's efforts in oncology and immunology while maintaining strong financial health evidenced by robust gross margins and dividend capabilities.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Bristol-Myers Squibb is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Bristol-Myers Squibb is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Bristol-Myers Squibb's data?

Start your 30-day free trial to request a data review for Bristol-Myers Squibb.

Start Free Trial

Legal Center Contact Us